Results 311 to 320 of about 427,029 (392)
Summary The efficacy of a triple combination of rabbit anti‐human thymocyte immunoglobulin (rATG), ciclosporin and eltrombopag (EPAG) was prospectively evaluated in patients with severe or transfusion‐dependent non‐severe aplastic anaemia (SAA) across 29 institutions in Japan. Sixty patients were enrolled, of whom 48 had SAA. The primary end‐point, the
Fumi Nakamura +17 more
wiley +1 more source
Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. [PDF]
Herrera-Hernández C +4 more
europepmc +1 more source
Summary Small nucleolar ribonucleic acids (snoRNAs) are a class of small non‐coding RNAs involved in the post‐transcriptional modification of ribosomal RNAs (rRNA) and small nuclear RNAs (snRNA). Mounting evidence indicates that specific snoRNAs are drivers of oncogenesis, but their role in B‐cell precursor acute lymphoblastic leukaemia (BCP‐ALL) is ...
Martijn W. C. Verbeek +13 more
wiley +1 more source
Albert Schweitzer, Chronic Myeloid Leukemia, and War.
Schalk E.
europepmc +1 more source
Long-term survival and successful pregnancy in a Nigerian woman with concurrent diagnosis of non-Hodgkin lymphoma and chronic myeloid leukemia: a case report. [PDF]
Ahmed IO +11 more
europepmc +1 more source
Advancing our understanding of the influence of myeloid-derived suppressor cells in chronic myeloid leukemia. [PDF]
Meng X +6 more
europepmc +1 more source
TAM family kinases are potential candidate targets for therapeutic intervention in chronic myeloid leukemia. [PDF]
Yousaf M, Arif K, Khan D.
europepmc +1 more source
Addressing complexity in the study of life sciences through Systems Biology and Systems Medicine has been transformative, making Systems Pharmacology the next logical step. In this review, we focus on physical stimuli, whose potential in pharmacology has been neglected, despite demonstrated therapeutic properties.
Veronica Paparozzi +10 more
wiley +1 more source

